Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Labroots Announces 7th Event in its Coronavirus Virtual Event Series, Hosted on May 4, 2022
  • USA - English
  • USA - English


News provided by

Labroots

Apr 28, 2022, 10:00 ET

Share this article

Share toX

Share this article

Share toX

Coronavirus Virtual Event, May 4, 2022
Coronavirus Virtual Event, May 4, 2022

This free, online event in the ongoing Series continues to bring together prominent speakers sharing the latest information as the world continues to navigate through the COVID-19 pandemic

YORBA LINDA, Calif., April 28, 2022 /PRNewswire-PRWeb/ -- Labroots, the leading scientific social networking website offering premier, interactive virtual events and webinars, announced the launch of the 7th educational event in its ongoing Coronavirus Virtual Event Series since their first in 2020. Under a virtual roof, the world's global leaders and experts from across various fields will present recent discoveries and breakthroughs and address the challenges of the COVID-19 pandemic via virtual discussions.

You won't want to miss the next conversations in this series with some of the brightest minds in science on an agenda aimed to encourage cross-disciplinary action toward a better world. Building on the success of Labroots' previous events in 2020 and 2021, this reputable forum brings together thousands of innovative research scholars, clinicians, and top scientists across leading medical, industry, and academic institutions. The preceding (six) events will remain on demand for two years garnering continuous viewing with record attendance.

The one-day jam-packed schedule features insights on the latest innovations and solutions captured in leading industry-sponsored presentations, keynote sessions followed by live Q&A, and on-demand discussions available for watching immediately upon the doors opening at 5:30 am PDT.

Kicking off the day, Dr. Kayvon Modjarrad (Director of the Emerging Infectious Diseases Branch at Walter Reed Army Institute of Research and Associate Professor) will deliver a keynote session on universal coronavirus vaccines from concept to clinic. In his keynote, Dr. Ralph S. Baric (Kenan Distinguished Professor of Epidemiology, Gillings School of Global Public Health at University of North Carolina) will explore SARS-CoV2 host range, viral genetics, replications, evolution, and transmission strategies framed in the context of the development of novel countermeasures to control COVID-19 disease severity in human populations. Finally, Dr. Abraham Flaxman (Associate Professor, Health Metrics Sciences, Institute for Health Metrics and Evaluation (IHME), the University of Washington) will present his topic on what happens after the mandates end and preparing for the next COVID-19 variant. All three keynote sessions are a must-see!

"The COVID-19 pandemic has altered public perception about the likelihood of new emerging diseases and their threat potential to human civilization," says Ralph Baric, Kenan Jr. Distinguished Professor of Epidemiology at the University of North Carolina at Chapel Hill. "As the 21st century has seen over ten new outbreaks, epidemic and pandemic viruses, new strategies in preparedness and global health are desperately needed to protect the public."

"The IHME COVID-19 Projection Model has been two years in the making, and it brings together all available data to help us understand where we are and how we have arrived here," said Abraham D. Flaxman, Associate Professor of Health Metrics Sciences at the Institute for Health Metrics and Evaluation at the University of Washington. "This can also help us prepare for what is to come if and when a new variant emerges."

The agenda includes exciting topics throughout the day, including a panel presentation sponsored by Thermo Fisher Scientific identifying different strategies for surveillance of SARS CoV-2 variants, and discussing Omicron variant features and significance. Their second panel presentation will demonstrate why saliva is an effective tool for infectious disease detection and how to serve your nucleic acid purification workflows better. In addition to keynote sessions and panel presentations, other event highlights will include informative lectures on COVID testing and the key to the beginning, middle, and end of the global pandemic, COVID – how did we get here and where are we going? Top 10 lessons learned from COVID focusing on minority populations and a way forward, wastewater-based surveillance of community health and more.

"We are thrilled to increase our global reach with our Coronavirus Virtual Event Series," commented Greg Cruikshank, Chief Executive Officer of Labroots. "Bringing yet another event in the Series to the scientific community and providing such critical and timely content and thought-provoking conversations from an extraordinary lineup of speakers has been very rewarding. As the world continues to navigate the COVID-19 pandemic, we are delighted to be at the forefront of sharing novel advancements and new technologies, so attendees can continue to explore unique insight gleaned through this year's presentations," Cruikshank added.

Produced on Labroots' robust platform while connecting across all desktop and mobile devices, the interactive environment delivers a complete educational experience for all participants. The event consists of a lobby with leaderboard and gamification, an auditorium featuring live-streaming video webcasts with live attendee chats during scheduled presentations, an exhibitor hall with sponsors booths, a poster hall to explore data and engage in live chat conversations and featuring a poster competition to give your research a competitive edge. And lastly, a networking lounge to make valuable connections with colleagues, including a social media wall and photo booth.

Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event in the series, you can earn 1 Continuing Education credit per presentation.

To register for the event, click here.

Connect with us and other members of the global Coronavirus research community by using the official event hashtag #LRcoronavirus! Follow us @Labroots on Twitter and @LabrootsInc on Facebook to connect with our team and stay up to date with the latest Trending News in Coronavirus research.

About Labroots
Labroots is the leading scientific social networking website, and primary source for scientific trending news and premier educational virtual events and webinars and more. Contributing to the advancement of science through content sharing capabilities, Labroots is a powerful advocate in amplifying global networks and communities. Founded in 2008, Labroots

Media Contact

Lynn Brainard, Labroots, 714-771-4397, [email protected]

Twitter

SOURCE Labroots

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.